^
BIOMARKER:

ID2 overexpression + TRIM33 overexpression

i
Other names: ID2, Inhibitor Of DNA Binding 2, BHLHb26, Inhibitor Of Differentiation 2, GIG8, Inhibitor Of DNA Binding 2, Dominant Negative Helix-Loop-Helix Protein, Class B Basic Helix-Loop-Helix Protein 26, DNA-Binding Protein Inhibitor ID-2, Cell Growth-Inhibiting Gene 8, Inhibitor Of DNA Binding 2, HLH Protein, DNA-Binding Protein Inhibitor ID2, Helix-Loop-Helix Protein ID2, BHLHB26, ID2A, ID2H, TRIM33, Tripartite Motif Containing 33, TIF1G, RFG7, Transcriptional Intermediary Factor 1 Gamma, RING-Type E3 Ubiquitin Transferase TRIM33, E3 Ubiquitin-Protein Ligase TRIM33, RET-Fused Gene 7 Protein, Ectodermin Homolog, Protein Rfg7, TIF1-Gamma, TIF1GAMMA, TIFGAMMA, KIAA1113, PTC7, TF1G, Transcription Intermediary Factor 1-Gamma, Tripartite Motif-Containing Protein 33, Tripartite Motif-Containing 33, Ret-Fused Gene 7, FLJ11429, ECTO
Entrez ID:
Related biomarkers:
News
Twitter
Trials
ID2 overexpression + TRIM33 overexpression
SCCHN
erlotinib
Sensitive: C3 – Early Trials
ID2 overexpression + TRIM33 overexpression
SCCHN
paclitaxel
Sensitive: C3 – Early Trials
ID2 overexpression + TRIM33 overexpression
SCCHN
crizotinib
Sensitive: C3 – Early Trials